TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI® (ublituximab-xiiy) data in patients with relapsing forms of multiple sclerosis (RMS), ...

Dear Editor A FREQUENTLY used cautionary adage among competent analysts is that “Statistics don’t lie, liars use statistics.” Quite often, this adage also ...

GH Research ( ($GHRS) ) has issued an update. GH Research PLC announced the presentation of data from its GH001-BD-202 clinical trial at the ...

Skywork AI is ideal for formal, data-driven presentations, while Gamma AI is better suited for visually engaging and ...

New data from two randomized trials suggest that dual antiplatelet therapy should be significantly shortened or not used at ...

Two former Meta employees told a Senate subcommittee Tuesday the social media giant suppressed critical research on risks ...

Shortly before the presentation of the iPhone 17, further and rather interesting details about the battery capacities. For ...

Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer patients alive, today shar ...

A Nigerian scholar, Elizabeth Oladipo, has earned global commendation after presenting groundbreaking research on how HIV ...

Ampligen has demonstrated data-driven promise in Progression-Free Survival and Overall Survival in both the DURIPANC clinical trial and an Early Access Program OCALA, Fla., Sept. 04, 2025 (GLOBE ...

On September 4, 2025, over 200 C-Suite leaders, localization executives, technology practitioners, investors, researchers, ...

The September issue of LCGC International delivers new perspectives in oligonucleotide analysis, robust data statistics, and advanced workflows for complex biologics.